Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction (Q58874452)
Jump to navigation
Jump to search
scientific article published on 01 October 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction |
scientific article published on 01 October 1998 |
Statements
Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction (English)
M del Cuerpo
M Sabaté
B Mirelis
1 October 1998